We are live on ! Find out more
ZVRA icon

Zevra Therapeutics
ZVRA

33 hedge funds and large institutions have $104M invested in Zevra Therapeutics in 2015 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

14% more funds holding

Funds holding: 29 → 33 (+4)

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

1% more capital invested

Capital invested by funds: $103M → $104M (+$1.48M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
33
Holders Change
+4
Holders Change %
+13.79%
% of All Funds
0.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
12
Increased
9
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$6.43M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$3.96M
3
CWG
C WorldWide Group
Denmark
+$3.16M
4
DCM
Driehaus Capital Management
Illinois
+$1.59M
5
DA
DSC Advisors
Illinois
+$1.54M

Top Sellers

Rank Fund Capital Flow
1
PCM
Pentwater Capital Management
Florida
-$8.94M
2
VAM
Visium Asset Management
New York
-$5.11M
3
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$3.36M
4
GTC
Ghost Tree Capital
New York
-$3.21M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.75M
Name Holding Trade Value Shares
Change 		Change in
Stake
BG
26
BlackRock Group
United Kingdom
$71K – – –
WRM
27
Westport Resources Management
Connecticut
$64K +$63.1K +206 New
PAM
28
Panagora Asset Management
Massachusetts
$56K +$55.1K +180 New
Barclays
29
Barclays
United Kingdom
$29K +$28.8K +94 New
WCM
30
Wealthcare Capital Management
Virginia
$19K – – –
BIM
31
BlackRock Investment Management
Delaware
$18K – – –
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$12K -$1.84K -6 -14%
TRCT
33
Tower Research Capital (TRC)
New York
$2K +$1.84K +6 New
PCM
34
Pentwater Capital Management
Florida
– -$8.94M -30,409 Closed
VAM
35
Visium Asset Management
New York
– -$5.11M -17,375 Closed
GTC
36
Ghost Tree Capital
New York
– -$3.21M -10,938 Closed
JP Morgan Chase
37
JP Morgan Chase
New York
– -$726K -2,468 Closed
SCM
38
Sio Capital Management
New York
– -$506K -1,721 Closed
VKH
39
Virtu KCG Holdings
New York
– -$323K -1,099 Closed
SG Americas Securities
40
SG Americas Securities
New York
– -$133K -451 Closed
UBS Group
41
UBS Group
Switzerland
– -$6K -19 Closed
1
2

ZVRA Hedge Fund Activity: Q3 2015 in Review

33 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Zevra Therapeutics (ZVRA) for Q3 2015, worth a combined $104M — up 1.4% from $103M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ZVRA positions and 8 closed out — a net gain of 4 holders — while 9 added to existing stakes and 8 trimmed.

The largest buyer was Deerfield Management, adding an estimated $6.43M. The largest seller was Pentwater Capital Management, exiting entirely with an estimated $8.94M sold.

  • 33 institutional investors held Zevra Therapeutics (ZVRA) as of Q3 2015, up from 29 in Q2 2015.
  • Funds reported $104M of Zevra Therapeutics stock for Q3 2015, up 1.4% quarter-over-quarter.
  • 12 funds opened new Zevra Therapeutics positions in Q3 2015 and 8 closed out, a net change of +4 holders.
  • The largest Zevra Therapeutics buyer in Q3 2015 was Deerfield Management, an estimated $6.43M added.
  • The largest Zevra Therapeutics seller in Q3 2015 was Pentwater Capital Management, an estimated $8.94M sold.

Based on aggregated 13F filings for Q3 2015.